{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:17:38Z","timestamp":1793733458748,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A6A1A03038899"],"award-info":[{"award-number":["2021R1A6A1A03038899"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C1083857"],"award-info":[{"award-number":["2019R1A2C1083857"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While their function, as immune checkpoint molecules, is well known, B7-family proteins also function as regulatory molecules in bone remodeling. B7\u2013H3 is a receptor ligand of the B7 family that functions primarily as a negative immune checkpoint. While the regulatory function of B7\u2013H3 in osteoblast differentiation has been established, its role in osteoclast differentiation remains unclear. Here we show that B7\u2013H3 is highly expressed in mature osteoclasts and that B7\u2013H3 deficiency leads to the inhibition of osteoclastogenesis in human osteoclast precursors (OCPs). High-throughput transcriptomic analyses reveal that B7\u2013H3 inhibition upregulates IFN signaling as well as IFN-inducible genes, including IDO. Pharmacological inhibition of type-I IFN and IDO knockdown leads to reversal of B7\u2013H3-deficiency-mediated osteoclastogenesis suppression. Although synovial-fluid macrophages from rheumatoid-arthritis patients express B7\u2013H3, inhibition of B7\u2013H3 does not affect their osteoclastogenesis. Thus, our findings highlight B7\u2013H3 as a physiologic positive regulator of osteoclast differentiation and implicate type-I IFN\u2013IDO signaling as its downstream mechanism.<\/jats:p>","DOI":"10.1038\/s41419-021-04275-6","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T14:01:02Z","timestamp":1634738462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["B7\u2013H3 regulates osteoclast differentiation via type I interferon-dependent IDO induction"],"prefix":"10.1038","volume":"12","author":[{"given":"Younseo","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungsin","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3542-2276","authenticated-orcid":false,"given":"Tae-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9772-1992","authenticated-orcid":false,"given":"Jong Dae","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"4275_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1210\/er.2007-0038","volume":"29","author":"J Lorenzo","year":"2008","unstructured":"Lorenzo J, Horowitz M, Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008;29:403\u201340.","journal-title":"Endocr Rev"},{"key":"4275_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007;7:292\u2013304.","journal-title":"Nat Rev Immunol"},{"key":"4275_CR3","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N. Engl J Med. 2011;365:2205\u201319. https:\/\/doi.org\/10.1056\/NEJMra1004965","journal-title":"N. Engl J Med"},{"key":"4275_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1196\/annals.365.035","volume":"1092","author":"DJ Hadjidakis","year":"2006","unstructured":"Hadjidakis DJ, Androulakis II. Bone remodeling. Ann N. Y Acad Sci. 2006;1092:385\u201396. https:\/\/doi.org\/10.1196\/annals.365.035","journal-title":"Ann N. Y Acad Sci"},{"key":"4275_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrd3669","volume":"11","author":"K Redlich","year":"2012","unstructured":"Redlich K, Smolen JS. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 2012;11:234\u201350. https:\/\/doi.org\/10.1038\/nrd3669","journal-title":"Nat Rev Drug Discov"},{"key":"4275_CR6","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1172\/JCI93356","volume":"127","author":"G Mbalaviele","year":"2017","unstructured":"Mbalaviele G, Novack DV, Schett G, Teitelbaum SL. Inflammatory osteolysis: a conspiracy against bone. J Clin Invest. 2017;127:2030\u20139. https:\/\/doi.org\/10.1172\/JCI93356. Epub 2017 Jun 1","journal-title":"J Clin Invest"},{"key":"4275_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.it.2013.07.003","volume":"34","author":"S Ceeraz","year":"2013","unstructured":"Ceeraz S, Nowak EC, Noelle RJ. B7 family checkpoint regulators in immune regulation and disease. Trends Immunol. 2013;34:556\u201363. https:\/\/doi.org\/10.1016\/j.it.2013.07.003. Epub Aug 13","journal-title":"Trends Immunol"},{"key":"4275_CR8","doi-asserted-by":"publisher","first-page":"104077","DOI":"10.1016\/j.cellimm.2020.104077","volume":"352","author":"Y Chen","year":"2020","unstructured":"Chen Y, Guan SY, Deng J, Yang H, Xu W, Xu S, et al. B7-H3: a promising therapeutic target for autoimmune diseases. Cell Immunol. 2020;352:104077 https:\/\/doi.org\/10.1016\/j.cellimm.2020.104077. Epub 2020 Feb 21","journal-title":"Cell Immunol"},{"key":"4275_CR9","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1074\/jbc.M115.680298","volume":"291","author":"BR Yoon","year":"2016","unstructured":"Yoon BR, Chung YH, Yoo SJ, Kawara K, Kim J, Yoo IS, et al. Preferential induction of the T cell auxiliary signaling molecule B7-H3 on synovial monocytes in rheumatoid arthritis. J Biol Chem. 2016;291:4048\u201357. https:\/\/doi.org\/10.1074\/jbc.M115.680298. Epub 2015 Dec 23","journal-title":"J Biol Chem"},{"key":"4275_CR10","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.4049\/jimmunol.180.5.2989","volume":"180","author":"CN Tran","year":"2008","unstructured":"Tran CN, Thacker SG, Louie DM, Oliver J, White PT, Endres JL, et al. Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3. J Immunol. 2008;180:2989\u201398. https:\/\/doi.org\/10.4049\/jimmunol.180.5.2989","journal-title":"J Immunol"},{"key":"4275_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2015.04.012","volume":"159","author":"J Sun","year":"2015","unstructured":"Sun J, Liu C, Gao L, Guo Y, Zhang Y, Wu P, et al. Correlation between B7-H3 expression and rheumatoid arthritis: a new polymorphism haplotype is associated with increased disease risk. Clin Immunol. 2015;159:23\u201332. https:\/\/doi.org\/10.1016\/j.clim.2015.04.012. Epub Apr 27","journal-title":"Clin Immunol"},{"key":"4275_CR12","doi-asserted-by":"publisher","first-page":"235ra60","DOI":"10.1126\/scitranslmed.3007764","volume":"6","author":"A Bozec","year":"2014","unstructured":"Bozec A, Zaiss MM, Kagwiria R, Voll R, Rauh M, Chen Z, et al. T cell costimulation molecules CD80\/86 inhibit osteoclast differentiation by inducing the IDO\/tryptophan pathway. Sci Transl Med. 2014;6:235ra60 https:\/\/doi.org\/10.1126\/scitranslmed.3007764","journal-title":"Sci Transl Med"},{"key":"4275_CR13","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.4049\/jimmunol.1600424","volume":"197","author":"CL Gigliotti","year":"2016","unstructured":"Gigliotti CL, Boggio E, Clemente N, Shivakumar Y, Toth E, Sblattero D, et al. ICOS-Ligand triggering impairs osteoclast differentiation and function in vitro and in vivo. J Immunol. 2016;197:3905\u201316. https:\/\/doi.org\/10.4049\/jimmunol.1600424. Epub 2016 Oct 19","journal-title":"J Immunol"},{"key":"4275_CR14","doi-asserted-by":"publisher","first-page":"12969","DOI":"10.1073\/pnas.0405259101","volume":"101","author":"WK Suh","year":"2004","unstructured":"Suh WK, Wang SX, Jheon AH, Moreno L, Yoshinaga SK, Ganss B, et al. The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization. Proc Natl Acad Sci USA. 2004;101:12969\u201373. https:\/\/doi.org\/10.1073\/pnas.0405259101. Epub 2004 Aug 18","journal-title":"Proc Natl Acad Sci USA"},{"key":"4275_CR15","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.4049\/jimmunol.0904020","volume":"185","author":"G Zhang","year":"2010","unstructured":"Zhang G, Wang J, Kelly J, Gu G, Hou J, Zhou Y, et al. B7-H3 augments the inflammatory response and is associated with human sepsis. J Immunol. 2010;185:3677\u201384. https:\/\/doi.org\/10.4049\/jimmunol.0904020. Epub 2010 Aug 9","journal-title":"J Immunol"},{"key":"4275_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4049\/jimmunol.1103715","volume":"189","author":"X Chen","year":"2012","unstructured":"Chen X, Quinn EM, Ni H, Wang J, Blankson S, Redmond HP, et al. B7-H3 participates in the development of experimental pneumococcal meningitis by augmentation of the inflammatory response via a TLR2-dependent mechanism. J Immunol. 2012;189:347\u201355. https:\/\/doi.org\/10.4049\/jimmunol.1103715. Epub 2012 Jun 1","journal-title":"J Immunol"},{"key":"4275_CR17","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/416744a","volume":"416","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature. 2002;416:744\u20139. https:\/\/doi.org\/10.1038\/416744a","journal-title":"Nature"},{"key":"4275_CR18","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.4049\/jimmunol.180.3.1382","volume":"180","author":"H Ha","year":"2008","unstructured":"Ha H, Lee JH, Kim HN, Kwak HB, Kim HM, Lee SE, et al. Stimulation by TLR5 modulates osteoclast differentiation through STAT1\/IFN-beta. J Immunol. 2008;180:1382\u20139. https:\/\/doi.org\/10.4049\/jimmunol.180.3.1382","journal-title":"J Immunol"},{"key":"4275_CR19","doi-asserted-by":"publisher","first-page":"15809","DOI":"10.1074\/jbc.M513225200","volume":"281","author":"H Zheng","year":"2006","unstructured":"Zheng H, Yu X, Collin-Osdoby P, Osdoby P. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF- kappaB that restrains osteoclastogenesis and bone resorption. J Biol Chem. 2006;281:15809\u201320. https:\/\/doi.org\/10.1074\/jbc.M513225200. Epub 2006 Apr 12","journal-title":"J Biol Chem"},{"key":"4275_CR20","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1016\/j.febslet.2012.06.047","volume":"586","author":"J Zhang","year":"2012","unstructured":"Zhang J, Zhao H, Chen J, Xia B, Jin Y, Wei W, et al. Interferon-beta-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF. FEBS Lett. 2012;586:3255\u201362. https:\/\/doi.org\/10.1016\/j.febslet.2012.06.047. Epub Jul 4","journal-title":"FEBS Lett"},{"key":"4275_CR21","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1002\/eji.201242572","volume":"42","author":"F Fallarino","year":"2012","unstructured":"Fallarino F, Grohmann U, Puccetti P. Indoleamine 2,3-dioxygenase: from catalyst to signaling function. Eur J Immunol. 2012;42:1932\u20137. 10.002\/eji.201242572","journal-title":"Eur J Immunol"},{"key":"4275_CR22","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ni.2077","volume":"12","author":"MT Pallotta","year":"2011","unstructured":"Pallotta MT, Orabona C, Volpi C, Vacca C, Belladonna ML, Bianchi R, et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol. 2011;12:870\u20138. https:\/\/doi.org\/10.1038\/ni.2077","journal-title":"Nat Immunol"},{"key":"4275_CR23","doi-asserted-by":"publisher","first-page":"962","DOI":"10.4049\/jimmunol.1502615","volume":"197","author":"Q Li","year":"2016","unstructured":"Li Q, Harden JL, Anderson CD, Egilmez NK. Tolerogenic phenotype of IFN-gamma-Induced IDO+ dendritic cells is maintained via an autocrine IDO-Kynurenine\/AhR-IDO loop. J Immunol. 2016;197:962\u201370. https:\/\/doi.org\/10.4049\/jimmunol.1502615. Epub 2016 Jun 17","journal-title":"J Immunol"},{"key":"4275_CR24","doi-asserted-by":"publisher","first-page":"9721","DOI":"10.1073\/pnas.0804231105","volume":"105","author":"A Kimura","year":"2008","unstructured":"Kimura A, Naka T, Nohara K, Fujii-Kuriyama Y, Kishimoto T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci USA. 2008;105:9721\u20136. https:\/\/doi.org\/10.1073\/pnas.0804231105. Epub 2008 Jul 7","journal-title":"Proc Natl Acad Sci USA"},{"key":"4275_CR25","doi-asserted-by":"publisher","first-page":"20768","DOI":"10.1073\/pnas.1009201107","volume":"107","author":"FJ Quintana","year":"2010","unstructured":"Quintana FJ, Murugaiyan G, Farez MF, Mitsdoerffer M, Tukpah AM, Burns EJ, et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2010;107:20768\u201373. https:\/\/doi.org\/10.1073\/pnas.1009201107. Epub 2010 Nov 10","journal-title":"Proc Natl Acad Sci USA"},{"key":"4275_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/toxsci\/kfq217","volume":"117","author":"B Zhao","year":"2010","unstructured":"Zhao B, Degroot DE, Hayashi A, He G, Denison MS. CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor. Toxicol Sci. 2010;117:393\u2013403. https:\/\/doi.org\/10.1093\/toxsci\/kfq217. Epub 2010 Jul 15","journal-title":"Toxicol Sci"},{"key":"4275_CR27","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1002\/art.22055","volume":"54","author":"TT Antoniv","year":"2006","unstructured":"Antoniv TT, Ivashkiv LB. Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages. Arthritis Rheum. 2006;54:2711\u201321. https:\/\/doi.org\/10.1002\/art.22055","journal-title":"Arthritis Rheum"},{"key":"4275_CR28","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1084\/jem.20021820","volume":"197","author":"JD Ji","year":"2003","unstructured":"Ji JD, Tassiulas I, Park-Min KH, Aydin A, Mecklenbrauker I, Tarakhovsky A, et al. Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. J Exp Med. 2003;197:1573\u201383. 10.084\/jem.20021820","journal-title":"J Exp Med"},{"key":"4275_CR29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.27200","volume":"62","author":"GD Kalliolias","year":"2010","unstructured":"Kalliolias GD, Zhao B, Triantafyllopoulou A, Park-Min KH, Ivashkiv LB. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL- mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Arthritis Rheum. 2010;62:402\u201313. 10.1002\/art.27200","journal-title":"Arthritis Rheum"},{"key":"4275_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1084\/jem.181.3.1015","volume":"181","author":"TK Sengupta","year":"1995","unstructured":"Sengupta TK, Chen A, Zhong Z, Darnell JE Jr., Ivashkiv LB. Activation of monocyte effector genes and STAT family transcription factors by inflammatory synovial fluid is independent of interferon gamma. J Exp Med. 1995;181:1015\u201325. 10.84\/jem.181.3","journal-title":"J Exp Med"},{"key":"4275_CR31","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3389\/fimmu.2017.01360","volume":"8","author":"AL Mellor","year":"2017","unstructured":"Mellor AL, Lemos H, Huang L. Indoleamine 2,3-dioxygenase and tolerance: where are we now? Front Immunol. 2017;8:1360 https:\/\/doi.org\/10.3389\/fimmu.2017.01360. eCollection 2017","journal-title":"Front Immunol"},{"key":"4275_CR32","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nri2163","volume":"7","author":"P Puccetti","year":"2007","unstructured":"Puccetti P, Grohmann U. IDO and regulatory T cells: a role for reverse signalling and non- canonical NF-kappaB activation. Nat Rev Immunol. 2007;7:817\u201323. https:\/\/doi.org\/10.1038\/nri2163","journal-title":"Nat Rev Immunol"},{"key":"4275_CR33","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/intimm\/dxh321","volume":"17","author":"F Fallarino","year":"2005","unstructured":"Fallarino F, Orabona C, Vacca C, Bianchi R, Gizzi S, Asselin-Paturel C, et al. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. Int Immunol. 2005;17:1429\u201338. 10.093\/intimm\/dxh321Epub 2005 Sep 19","journal-title":"Int Immunol"},{"key":"4275_CR34","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.4049\/jimmunol.174.11.6582","volume":"174","author":"C Orabona","year":"2005","unstructured":"Orabona C, Belladonna ML, Vacca C, Bianchi R, Fallarino F, Volpi C, et al. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. J Immunol. 2005;174:6582\u20136. https:\/\/doi.org\/10.4049\/jimmunol.174.11.6582","journal-title":"J Immunol"},{"key":"4275_CR35","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/ni1124","volume":"5","author":"C Orabona","year":"2004","unstructured":"Orabona C, Grohmann U, Belladonna ML, Fallarino F, Vacca C, Bianchi R, et al. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat Immunol. 2004;5:1134\u201342. 10.038\/ni24Epub 2004 Oct 3","journal-title":"Nat Immunol"},{"key":"4275_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1623-0","volume":"10","author":"X Zheng","year":"2019","unstructured":"Zheng X, Xiao ZX, Hu L, Fang X, Luo L, Chen L. Dendritic cell-associated B7-H3 suppresses the production of autoantibodies and renal inflammation in a mouse model of systemic lupus erythematosus. Cell Death Dis. 2019;10:393 https:\/\/doi.org\/10.1038\/s41419-019-1623-0","journal-title":"Cell Death Dis"},{"key":"4275_CR37","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","volume":"192","author":"MK Crow","year":"2014","unstructured":"Crow MK. Type I interferon in the pathogenesis of lupus. J Immunol. 2014;192:5459\u201368. https:\/\/doi.org\/10.4049\/jimmunol.1002795","journal-title":"J Immunol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04275-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04275-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04275-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T12:01:55Z","timestamp":1699704115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04275-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["4275"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-04275-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"assertion":[{"value":"12 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"971"}}